Sign in

CIK 0001422143

  • Non-accelerated filer
  • Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547851
Phone
+1 858-500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
  1. 4 Grant or award Chief Legal Officer acquired 46,250 shares (grant or award)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Gift President and CEO gave 3,000 shares (gift)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market buy Director bought 50,000 shares at $11.50 ($575,000)
  8. 4 Other disposition President and CEO disposed of 890,178 shares (other)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award SVP, Finance & Accounting acquired 10,625 shares (grant or award)
  16. 4 Grant or award Chief Legal Officer acquired 23,125 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 4 Grant or award Chief Medical Officer acquired 23,125 shares (grant or award)
  19. 4 Other disposition President and CEO disposed of 1,623,608 shares (other)
  20. 4 Open-market sale Chief Operating Officer sold 1,821 shares at $13.89 ($25,294)

Page 6 of 14 · 277 filings